Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer

Radiotherapy and Oncology

Volumn 69, Issue 2, 2003, Pages 215-222

  Greco, Carlo ^a   Mazzetta, Chiara ^a   Cattani, Federica ^a   Tosi, Giampiero ^a   Castiglioni, Simona ^a   Fodor, Andrei ^a   Orecchia, Roberto ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Conformal radiotherapy; Dose volume histograms; Prostate; Rectal toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; FISHER EXACT TEST; FOLLOW UP; HISTOGRAM; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION EXPOSURE; RECTUM; RECTUM HEMORRHAGE; RECTUM TOXICITY; RETROSPECTIVE STUDY; TOXICITY; TUMOR VOLUME;

EID: 0345303979     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.08.003     Document Type: Article

References (45)

1. Antolak J.A., Rosen I.I., Childress C.H., Zagars G.K., Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 42:1998;661-672.
2. Benk V.A., Adams J.A., Shipley W.U., et al. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys. 26:1993;551-557.
3. Boersma L.J., van den B.M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
4. Cheng C.W., Das I.J. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH). Int J Radiat Oncol Biol Phys. 43:1999;1143-1150.
5. Chism D.B., Horwitz E.M., Hanlon A.L., Pinover W.H., Mitra R.K., Hanks G.E. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys. 55:2003;71-77.
6. Dale E., Olsen D.R., Fossa S.D. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 43:1999;385-391.
7. Denham J.W., Hauer-Jensen M. The radiotherapeutic injury - a complex wound. Radiother Oncol. 63:2002;129-145.
8. Fenwick J.D., Khoo V.S., Nahum A.E., Sanchez-Nieto B., Dearnaley D.P. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 49:2001;473-480.
9. Fiorino C., Cozzarini C., Vavassori V., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol. 64:2002;1-12.
10. Fiorino C., Vavassori V., Sanguineti G., et al. Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability. Radiother Oncol. 63:2002;249-255.
11. Ghilezan M., Ivaldi G., Cattani F., et al. 3D-conformal radiation therapy in prostate cancer. Technical considerations after 5 years of experience and 334 patients treated at the Istituto Europeo di Oncologia of Milan, Italy. Tumori. 87:2001;317-323.
12. Hanks G.E., Hanlon A.L., Pinover W.H., Horwitz E.M., Price R.A., Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 46:2000;823-832.
13. Hanks G.E., Hanlon A.L., Pinover W.H., Horwitz E.M., Schultheiss T.E. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 5:1999;152-158.
14. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510.
15. Hartford A.C., Niemierko A., Adams J.A., Urie M.M., Shipley W.U. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys. 36:1996;721-730.
16. Horwitz E.M., Hanlon A.L., Pinover W.H., Anderson P.R., Hanks G.E. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer. 92:2001;1281-1287.
17. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 54:2002;1314-1321.
18. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 49:2001;685-698.
19. Kestin L., Goldstein N., Vicini F., Yan D., Korman H., Martinez A. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume? Int J Radiat Oncol Biol Phys. 54:2002;686-697.
20. Kutcher G.J., Leibel S.A., Ling C.C., Zelefsky M., Fuks Z. New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate. Int J Radiat Oncol Biol Phys. 35:1996;415-416.
21. Lawton C.A., Won M., Pilepich M.V., et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:1991;935-939.
22. Lebesque J.V., Bruce A.M., Kroes A.P., Touw A., Shouman R.T., van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 33:1995;1109-1119.
23. Levegrun S., Jackson A., Zelefsky M.J., et al. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. Int J Radiat Oncol Biol Phys. 47:2000;1245-1260.
24. Lu Y., Li S., Spelbring D., et al. Dose-surface histograms as treatment planning tool for prostate conformal therapy. Med Phys. 22:1995;279-284.
25. Lu Y., Song P.Y., Li S.D., et al. A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 33:1995;1121-1125.
26. Lyman J.T., Wolbarst A.B. Optimization of radiation therapy. III. A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys. 13:1987;103-109.
27. MacKay R.I., Hendry J.H., Moore C.J., Williams P.C., Read G. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol. 70:1997;517-526.
28. Meijer G.J., van den B.M., Hoogeman M.S., Meinders J., Lebesque J.V. Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy. Int J Radiat Oncol Biol Phys. 45:1999;1073-1080.
29. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 46:2000;391-402.
30. O'Brien P.C. Radiation injury of the rectum. Radiother Oncol. 60:2001;1-14.
31. Parker C., Haycocks T., Bayley A., Alasti H., Warde P., Catton C. A dose-volume histogram analysis of the seminal vesicles in men treated with conformal radiotherapy to prostate alone. Clin Oncol (R Coll Radiol). 14:2002;298-302.
32. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;1321-1329.
33. Sanguineti G., Agostinelli S., Foppiano F., et al. Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma. Br J Cancer. 86:2002;1843-1847.
34. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;3-11.
35. Shu H.K., Lee T.T., Vigneauly E., et al. Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology. 57:2001;102-107.
36. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys. 47:2000;103-113.
37. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642.
38. Tinger A., Michalski J.M., Cheng A., et al. A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;213-221.
39. Vicini F.A., Abner A., Baglan K.L., Kestin L.L., Martinez A.A. Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better? Int J Radiat Oncol Biol Phys. 51:2001;1200-1208.
40. Wachter S., Gerstner N., Goldner G., Potzi R., Wambersie A., Potter R. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol. 59:2001;65-70.
41. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol. 61:2001;127-133.
42. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468.
43. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 53:2002;1111-1116.
44. Zelefsky M.J., Fuks Z., Leibel S.A. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol. 12:2002;229-237.
45. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.